These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32940893)

  • 1. Efficacy of Sodium Tanshinone IIA Sulfonate in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Controlled, Randomized Trial.
    Mao S; Wang L; Zhao X; Guo L; Lin Q; Wang X; Dai X; Shang H; Zhang M; Hinek A
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):321-329. PubMed ID: 32940893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effects of Salvianolate on Myocardial Injury or Myocardial Infarction after Elective Percutaneous Coronary Intervention in NSTE-ACS Patients: A Randomized Placebo-Controlled Trial.
    Ou Y; Sun SJ; Shi HM; Luo JF; Luo XP; Shen YZ; Chen YF; Fan WH; Liu HY; Shen W
    Chin J Integr Med; 2020 Sep; 26(9):656-662. PubMed ID: 32572777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome.
    Gargiulo G; Carrara G; Frigoli E; Leonardi S; Vranckx P; Campo G; Varbella F; Calabrò P; Zaro T; Bartolini D; Briguori C; Andò G; Ferrario M; Limbruno U; Colangelo S; Sganzerla P; Russo F; Nazzaro MS; Esposito G; Ferrante G; Santarelli A; Sardella G; Windecker S; Valgimigli M
    J Am Coll Cardiol; 2019 Feb; 73(7):758-774. PubMed ID: 30784669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy).
    Lansky AJ; Ng VG; Meller S; Xu K; Fahy M; Feit F; Ohman EM; White HD; Mehran R; Bertrand ME; Desmet W; Hamon M; Stone GW
    JACC Cardiovasc Interv; 2014 Mar; 7(3):266-75. PubMed ID: 24650400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial.
    Lopes RD; de Barros E Silva PGM; de Andrade Jesuíno I; Santucci EV; Barbosa LM; Damiani LP; Nakagawa Santos RH; Laranjeira LN; Dall Orto FTC; Beraldo de Andrade P; de Castro Bienert IR; Alexander JH; Granger CB; Berwanger O
    JAMA Cardiol; 2018 Nov; 3(11):1113-1118. PubMed ID: 30264159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium tanshinone IIA sulfonate for reduction of periprocedural myocardial injury during percutaneous coronary intervention (STAMP trial): rationale and design.
    Mao S; Wang L; Zhao X; Shang H; Zhang M; Hinek A
    Int J Cardiol; 2015 Mar; 182():329-33. PubMed ID: 25585378
    [No Abstract]   [Full Text] [Related]  

  • 7. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
    Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, clinical determinants and prognostic implications of coronary procedural complications of percutaneous coronary intervention in non-ST-segment elevation myocardial infarction: Insights from the contemporary multinational TAO trial.
    Abtan J; Wiviott SD; Sorbets E; Popovic B; Elbez Y; Mehta SR; Sabatine MS; Bode C; Pollack CV; Cohen M; Moccetti T; Laanmets P; Faxon D; Okreglicki A; Ducrocq G; Steg PG;
    Arch Cardiovasc Dis; 2021 Mar; 114(3):187-196. PubMed ID: 33518473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Danlou Tablet () on peri-procedural myocardial injury among patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndrome: A study protocol of a multicenter, randomized, controlled trial.
    Wang L; Mao S; Qi JY; Ren Y; Guo XF; Chen KJ; Zhang MZ
    Chin J Integr Med; 2015 Sep; 21(9):662-6. PubMed ID: 26142341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
    Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early versus delayed percutaneous coronary intervention for patients with non-ST segment elevation acute coronary syndrome: a meta-analysis of randomized controlled clinical trials.
    Rajpurohit N; Garg N; Garg R; Choudhary A; Fresen J; Boren S; Dellsperger KC; Webel R; Aggarwal K; Alpert MA
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):223-31. PubMed ID: 22488783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence.
    Borovac JA; Leth-Olsen M; Kumric M; D'Amario D; Schwarz K; Glavas D; Bozic J
    Eur J Clin Pharmacol; 2022 Jan; 78(1):111-126. PubMed ID: 34423376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
    Murai T; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Hamaya R; Kanno Y; Lee T; Kakuta T
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1063-1074. PubMed ID: 29446567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome.
    Hassanin A; Brener SJ; Lansky AJ; Xu K; Stone GW
    EuroIntervention; 2015 Jul; 11(3):293-300. PubMed ID: 25136882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials.
    Kan Z; Yan W; Yang M; Gao H; Meng D; Wang N; Fang Y; Wu L; Song Y
    Front Pharmacol; 2023; 14():1144419. PubMed ID: 36959861
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects on Suxiao Jiuxin Pills in the Treatment of Patients with Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention: A Multicenter Randomized Double-Blind Placebo-Controlled Trial.
    Shen Z; Chen T; Deng B; Fan M; Hua J; Zhang M; Wang X
    J Altern Complement Med; 2020 Nov; 26(11):1055-1063. PubMed ID: 32716206
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
    Berwanger O; Santucci EV; de Barros E Silva PGM; Jesuíno IA; Damiani LP; Barbosa LM; Santos RHN; Laranjeira LN; Egydio FM; Borges de Oliveira JA; Dall Orto FTC; Beraldo de Andrade P; Bienert IRC; Bosso CE; Mangione JA; Polanczyk CA; Sousa AGMR; Kalil RAK; Santos LM; Sposito AC; Rech RL; Sousa ACS; Baldissera F; Nascimento BR; Giraldez RRCV; Cavalcanti AB; Pereira SB; Mattos LA; Armaganijan LV; Guimarães HP; Sousa JEMR; Alexander JH; Granger CB; Lopes RD;
    JAMA; 2018 Apr; 319(13):1331-1340. PubMed ID: 29525821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial).
    Patti G; Pasceri V; Mangiacapra F; Colonna G; Vizzi V; Ricottini E; Montinaro A; D'Ambrosio A; Wijns W; Barbato E; Di Sciascio G;
    Am J Cardiol; 2013 Jul; 112(2):162-8. PubMed ID: 23601577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry.
    Bauer T; Zeymer U; Hochadel M; Möllmann H; Weidinger F; Zahn R; Nef HM; Hamm CW; Marco J; Gitt AK
    Int J Cardiol; 2013 Jul; 166(3):596-600. PubMed ID: 22192297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.